Purchase Order 12405B19P0415
- Not listed
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the delivery of RNA sequencing kits, ligation sequencing kits, rapid barcoding kits, and flow cells. The $70,000.00 firm-fixed-price purchase order was awarded by the Southeast Area office of a civilian federal agency. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts to provide...
- Oxford Nanopore Technologies Inc. received a firm fixed-price purchase order from a civilian federal agency with a Midwest Area office on August 25, 2018, for nanopore DNA sequencing kits, training, and flow cells with a ceiling value of $7.1K. The contract was completed by September 24, 2018, with performance undertaken in Columbia, Missouri. No set-aside designation was applied to this award. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in...
- Oxford Nanopore Technologies Inc. was awarded a $47,960 firm fixed-price purchase order by a civilian federal agency (Midwest Area) on December 6, 2019, for genomic sequencing consumables and reagents. The contract, which was set aside for total small business, called for the delivery of MinION flow cells (FLO-MIN 106D R9 and FLO-MIN 110 R10 models) and ligation sequencing kits (SQK-LSK109), with an ultimate completion date of December 20, 2019. The place of performance was Cambridge, MA, and...
- Oxford Nanopore Technologies Inc. was awarded a $79,026 firm fixed-price purchase order on August 23, 2017, for the delivery of flow cells and sequencing kits to a civilian federal agency in the Southeast Area. The contract, with a completion date of September 1, 2017, was not issued under a set-aside designation. The work will be performed in Gainesville, Florida. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in nanopore-based electronic sequencing...
- This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
- This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of nanopore flow-cells and a ligation kit. The $19,227.99 firm fixed-price purchase order was awarded by the Northeast Area division of the U.S. Department of Agriculture's Agricultural Research Service. The contract has an ultimate completion date of May 10, 2024. Oxford Nanopore has secured multiple federal contracts and Indefinite Delivery Vehicles (IDVs)...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...
- This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
- This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit organization, to provide MINION-2 SEQUENCERS. The contract has a ceiling value of $38,062 and a completion date of October 9, 2020. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
Oxford Nanopore Technologies Inc. received a $95,605 firm fixed-price purchase order (Contract #GRD-CAPEX) from a civilian Southeast Area federal agency for genomic sequencing equipment and services, with performance in Cambridge, Massachusetts. The contract was awarded on September 5, 2019, with an ultimate completion date of October 4, 2019. This award was not associated with a small business set-aside designation. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology firm specializing in nanopore-based electronic systems for DNA, RNA, and protein analysis, has maintained an extensive portfolio of federal contracts across multiple agencies including the National Institutes of Health, Centers for Disease Control and Prevention, U.S. Department of Agriculture, Department of Defense, and Food and Drug Administration, supplying advanced sequencing platforms such as GridION, PromethION, and MinION systems. The parent company, Oxford Nanopore Technologies PLC (United Kingdom-based), has also been awarded federal contracts directly, notably including a $167,924 purchase order from the CDC for COVID-19 detection products completed in March 2022. Oxford Nanopore maintains several significant Indefinite Delivery Vehicles with federal agencies, including a $325,000 Blanket Purchase Agreement with the Defense Health Agency through February 2029 and a $740,000 Indefinite Delivery Contract with USDA's Animal and Plant Health Inspection Service through August 2029, enabling streamlined procurement of sequencing technologies, consumables, reagents, and services for critical research applications spanning infectious disease tracking, agricultural genomics, and biomedical studies.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Sequencing Instrument | 12405B19Q0048 | Department of Agriculture Agricultural Research Service Field Research Implementation and Information Delivery | Award Notice 1/1 | 8/22/19, 9:47 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.6k | 9/6/19 |